| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 2,678 | $39.23 | $105,057.94 | -6.4% | -28.5% | - | |
| Dec 2, 2025 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 28,876 | $592.70 | $17,114,846.56 | -2.2% | -21.6% | - | |
| Dec 2, 2025 | TMO Thermo Fisher Scientific Inc. | Lowery Frederick M.65 | Executive Vice President | Sell | 13,825 | $589.81 | $8,154,131.12 | -32.5% | -12.4% | - | |
| Dec 1, 2025 | GH Guardant Health, Inc. | Monroe Terilyn J. | Chief People Officer | Sell | 55,167 | $105.97 | $5,846,163.49 | -20.8% | -12.3% | - | |
| Dec 1, 2025 | A Agilent Technologies, Inc. | Dolsten Mikael56 | Director | Sell | 2,600 | $149.81 | $389,511.20 | -34.3% | -21.3% | - | |
| Dec 1, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 377 | $162.54 | $61,276.07 | -8.2% | -54.6% | - | |
| Dec 1, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 4,400 | $238.07 | $1,047,501.95 | -1.0% | -14.5% | - | |
| Dec 1, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 3,000 | $238.15 | $714,458.77 | -0.7% | -14.5% | - | |
| Dec 1, 2025 | NOTV Inotiv, Inc. | Neff R Matthew92 | Director | Sell | 2,000 | $0.89 | $1,770.60 | -1.3% | -65.1% | - | |
| Nov 28, 2025 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | President And COO | Sell | 1,198 | $29.57 | $35,424.26 | -0.4% | -16.4% | - | |
| Nov 28, 2025 | FLGT Fulgent Genetics, Inc. | Gao Hanlin73 | Chief Scientific Officer | Sell | 943 | $29.57 | $27,884.04 | - | -16.4% | - | |
| Nov 28, 2025 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 56,482 | $603.28 | $34,074,469.74 | -4.0% | -24.6% | - | |
| Nov 26, 2025 | A Agilent Technologies, Inc. | Gonsalves Rodney65 | V.p., Corporate Controller | Sell | 3,000 | $154.99 | $464,955.90 | -8.6% | -19.4% | - | |
| Nov 26, 2025 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 4,258 | $40.09 | $170,703.22 | -9.3% | -25.0% | - | |
| Nov 25, 2025 | DHR Danaher Corp /de/ | Rales Mitchell P70 | Chairman Of Exec. Committee | Sell | 40,625 | $230.38 | $9,359,066.67 | -2.3% | -8.6% | - | |
| Nov 25, 2025 | TMO Thermo Fisher Scientific Inc. | Shafer Michael D | Executive Vice President | Sell | 10,725 | $600.00 | $6,435,000.00 | -22.3% | -13.6% | - | |
| Nov 25, 2025 | NEO Neogenomics Inc | Olivo Alicia C69 | EVP, GC &Business Development | Sell | 20,916 | $12.00 | $250,992.00 | -40.2% | -19.2% | - | |
| Nov 25, 2025 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 5,115 | $40.05 | $204,850.64 | -10.0% | -27.5% | - | |
| Nov 25, 2025 | MTD Mettler Toledo International Inc/ | De La Guerroniere Marc56 | Head Of Eur &Na Market Orgs | Sell | 6,055 | $1,488.18 | $9,010,900.00 | -68.0% | -7.5% | - | |
| Nov 25, 2025 | VCYT Veracyte, Inc. | Jones Evan/ Fa70 | Director | Sell | 1,106 | $50.25 | $55,575.73 | -3.6% | -27.6% | - | |
| Nov 25, 2025 | VCYT Veracyte, Inc. | Leite John51 | Chief Commercial Officer-clia | Sell | 2,808 | $50.00 | $140,400.00 | -3.2% | -27.6% | - | |
| Nov 25, 2025 | PSNL Personalis, Inc. | Tachibana Aaron68 | CFO And COO | Sell | 103,668 | $10.78 | $1,117,541.04 | -38.7% | -26.1% | - | |
| Nov 25, 2025 | MTD Mettler Toledo International Inc/ | Vadala Shawn68 | Chief Financial Officer | Sell | 2,025 | $1,481.14 | $2,999,300.00 | -16.1% | -7.5% | - | |
| Nov 25, 2025 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 101,417 | $611.02 | $61,967,338.34 | -6.3% | -27.3% | - | |
| Nov 24, 2025 | NTRA Natera, Inc. | Botha Roelof81 | Director | Sell | 75,000 | $236.12 | $17,708,935.58 | -0.6% | -12.3% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.